非小細胞肺癌:世界市場(医薬品市場予測及び分析~2022)...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 17
1.2 List of Figures 23
2 Introduction 25
2.1 Catalyst 25
2.2 Related Reports 26
2.3 Upcoming Related Reports 26
3 Disease Overview 27
3.1 Etiology and Pathophysiology 27
3.1.1 Etiology 27
3.1.2 Pathophysiology and Histology 27
3.1.3 NSCLC Biomarkers 28
3.1.4 Quality of Life 29
3.2 Symptoms 30
4 Epidemiology 31
4.1 Risk Factors and Comorbidities 32
4.1.1 Smokers are more likely to have lung cancer than non-smokers 33
4.1.2 Long-term exposure to radon increases the risk of lung cancer 35
4.1.3 Family history of any cancer increases lung cancer risk 35
4.1.4 TB increases the risk of lung cancer and increases mortality risk 35
4.1.5 COPD is a comorbidity that reduces lung cancer survival 36
4.1.6 Lung cancer screening programs may not be beneficial 36
4.1.7 Stage at diagnosis significantly impacts the survival of lung cancer cases 37
4.2 Global Trends 38
4.2.1 US 41
4.2.2 France 46
4.2.3 Germany 47
4.2.4 Italy 49
4.2.5 Spain 51
4.2.6 UK 53
4.2.7 Japan 54
4.2.8 China 56
4.2.9 India 58
4.3 Forecast Methodology 60
4.3.1 Sources Used 61
4.3.2 Sources Not Used 66
4.3.3 Forecast Assumptions and Methods 67
4.4 Epidemiology Forecast (2012-2022) 69
4.4.1 Incident/Prevalent Cases of NSCLC 69
4.4.2 Age-Specific Incident Cases of NSCLC 71
4.4.3 Sex-Specific Incident Cases of NSCLC 72
4.4.4 Age-Standardized Incidence Rates of NSCLC 74
4.4.5 Segmentation of NSCLC Incident Cases 75
4.5 Discussion 83
4.5.1 Limitations of the Analysis 84
4.5.2 Strengths of the Analysis 85
5 Disease Management 86
5.1 Treatment Overview 86
5.1.1 Diagnosis 87
5.1.2 Clinical Staging 88
5.1.3 Screening and Early Detection 89
5.1.4 Localized Procedures and Therapies 91
5.1.5 Systemic Chemotherapy 91
5.1.6 Targeted Therapy 92
5.2 US 94
5.2.1 Diagnosis 94
5.2.2 Clinical Practice 95
5.3 France 97
5.3.1 Diagnosis 97
5.3.2 Clinical Practice 98
5.4 Germany 99
5.4.1 Diagnosis 99
5.4.2 Clinical Practice 100
5.5 Italy 102
5.5.1 Diagnosis 102
5.5.2 Clinical Practice 102
5.6 Spain 103
5.6.1 Diagnosis 103
5.6.2 Clinical Practice 104
5.7 UK 105
5.7.1 Diagnosis 105
5.7.2 Clinical Practice 105
5.8 Japan 107
5.8.1 Diagnosis 107
5.8.2 Clinical Practice 107
5.9 China 109
5.9.1 Diagnosis 109
5.9.2 Clinical Practice 109
5.10 India 110
5.10.1 Diagnosis 110
5.10.2 Clinical Practice 111
6 Competitive Assessment 113
6.1 Overview 113
6.2 Strategic Competitor Assessment 114
6.3 Product Profiles – Major Brands, Chemotherapies 116
6.3.1 Alimta (pemetrexed disodium) 116
6.3.2 Abraxane (nab-paclitaxel) 121
6.4 Product Profiles – Major Brands, Targeted Therapies 125
6.4.1 Iressa (gefitinib) 125
6.4.2 Tarceva (erlotinib hydrochloride) 130
6.4.3 Xalkori (crizotinib) 136
6.4.4 Avastin (bevacizumab) 141
7 Opportunity and Unmet Need 145
7.1 Overview 145
7.2 Improved Overall Survival and Less Toxicity 147
7.3 Treatments for Patients with Acquired TKI Resistance 147
7.4 Better Treatment Options for Squamous Patients 148
7.5 Preventing Relapse or Recurrence 149
7.6 More Efficacious Second-Line Therapies 149
7.7 Increased Availability of Mutation Testing 150
7.8 More Cost-Effective Therapies 150
7.9 Unmet Needs Gap Analysis 151
8 Pipeline Assessment 154
8.1 Overview 154
8.2 Clinical Trial Mapping 155
8.2.1 Clinical Trials by Country 155
8.3 Clinical Trials by Phase and Trial Status 156
8.4 Promising Drugs in Clinical Development 157
8.4.1 onartuzumab (MetMab) 160
8.4.2 necitumumab (IMC-11F8) 167
8.4.3 ramucirumab (IMC-1121B) 173
8.4.4 custirsen (OGX-011) 178
8.4.5 ganetespib (STA-9090) 184
8.4.6 nintedanib (BIBF1120) 191
8.4.7 afatinib (BIBW-2992) 196
8.4.8 dacomitinib (PF-00299804) 202
8.4.9 LDK378 207
8.4.10 Yervoy (ipilimumab) 213
8.4.11 nivolumab (BMS936558) 218
8.4.12 GSK1572932A (MAGE-A3 Cancer Immunotherapeutic) 225
8.4.13 Halaven (eribulin mesylate) 230
9 Current and Future Players 234
9.1 Overview 234
9.2 Trends in Corporate Strategy 237
9.3 Company Profiles 238
9.3.1 Roche/Genentech 238
9.3.2 Pfizer 241
9.3.3 Bristol-Myers Squibb 243
9.3.4 Eli Lilly 245
9.3.5 Boehringer Ingelheim 248
9.3.6 Novartis 250
10 Market Outlook 251
10.1 Global Markets 251
10.1.1 Forecast 251
10.1.2 Drivers and Barriers – Global Issues 255
10.2 United States 258
10.2.1 Forecast 258
10.2.2 Key Events 261
10.2.3 Drivers and Barriers 262
10.3 France 265
10.3.1 Forecast 265
10.3.2 Key Events 268
10.3.3 Drivers and Barriers 269
10.4 Germany 271
10.4.1 Forecast 271
10.4.2 Key Events 274
10.4.3 Drivers and Barriers 275
10.5 Italy 277
10.5.1 Forecast 277
10.5.2 Key Events 280
10.5.3 Drivers and Barriers 281
10.6 Spain 283
10.6.1 Forecast 283
10.6.2 Key Events 285
10.6.3 Drivers and Barriers 286
10.7 United Kingdom 288
10.7.1 Forecast 288
10.7.2 Key Events 292
10.7.3 Drivers and Barriers 293
10.8 Japan 295
10.8.1 Forecast 295
10.8.2 Key Events 299
10.8.3 Drivers and Barriers 299
10.9 China 302
10.9.1 Forecast 302
10.9.2 Key Events 305
10.9.3 Drivers and Barriers 305
10.10 India 308
10.10.1 Forecast 308
10.10.2 Key Events 312
10.10.3 Drivers and Barriers 312
11 Appendix 314
11.1 Bibliography 314
11.2 Abbreviations 344
11.3 Methodology 349
11.4 Forecasting Methodology 349
11.4.1 Number of NSCLC Patients Currently Seeking Treatment 349
11.4.2 Percent Drug-treated Patients 350
11.4.3 Drugs Included in Each Therapeutic Class 350
11.4.4 Launch and Patent Expiry Dates 351
11.4.5 General Pricing Assumptions 352
11.4.6 Individual Drug Assumptions 355
11.4.7 Generic Erosion 366
11.4.8 Pricing of Pipeline Agents 366
11.5 Physicians and Specialists Included in This Study 369
11.6 Survey of Prescribing Physicians 371
11.7 About the Authors 372
11.7.1 Author 372
11.7.2 Epidemiologist 372
11.7.3 Global Head of Healthcare 373
11.8 About GlobalData 374
11.9 Disclaimer 374


【レポート販売概要】

■ タイトル:非小細胞肺癌:世界市場(医薬品市場予測及び分析~2022)
■ 英文:PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022
■ 発行日:2013年6月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161300
■ 調査対象地域:グローバル
  • 世界のプロセス自動化市場動向(2012-2016)
    TechNavio's analysts forecast the Global Process Automation market to grow at a CAGR of 6.62 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for automation solutions from the Oil and Gas industry. The Global Process Automation market has also been witnessing an increasing availability of wireless sensor networking. However, the …
  • アクションカメラの世界市場2015-2019
    About Action Cameras Action cameras are used to capture extreme action sports or activities. These cameras can capture high-speed and high-quality images. Regular cameras are incapable of capturing high-speed actions and are not designed for rugged conditions, including extreme weather. By contrast, action cameras are compact, lightweight, designed for rugged conditions, and can be worn by the per …
  • シニア層向け食品のマーケティング差別化
    Summary How to differentiate Marketing between Aging Consumers and Other Audiences in Food markets shows marketers how they can target the emerging opportunities among an important, under-targeted, and misunderstood consumer group: older consumers. An aging population means the consumption of those aged 55 and over will only grow, and to successfully cater to them, it is important for manufacturer …
  • アプリストアの将来(The Future of App Stores)
    There are now millions of mobile applications running on the popular mobile operating systems. Mobile applications are distributed via app stores which provide directory and search services that assist users in identify and acquiring the apps they most desire. This report provides a summary of the status of app stores in the market today. It presents a number of features common to all app stores. …
  • Gaucher’s Disease:グローバル臨床試験レビューH2, 2013
    Gaucher's Disease Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Gaucher's Disease Global Clinical Trials Review, H2, 2013" provides data on the Gaucher’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gaucher’s Disease. It includes an overview of the trial numbers and their recruitment s …
  • スクラレオールの世界市場2015
    Sclareol (CAS 515-03-7) Market Research Report 2015 aims at providing comprehensive data on Sclareol market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Sclareol description, covers its application areas, manufacturing methods, patterns. It captures Sclareol market trends, pays close attention to Sclareol manufacturers and names suppliers. Besides, …
  • グローバル口腔衛生製品市場におけるM&A動向(2014年3月)
    Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global oral hygiene market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global oral hygiene market throughout the month. Additionally, the report provides an overview of all the …
  • 世界の軍用レーダ市場動向2013-2023:市場のSWOT分析
    This SWOT analysis of Military Radar market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's "The Global Military Radar Market 2013-2023 - SWOT Analysis: Market Profile" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. SDI strictly follows …
  • 世界のオーバーザトップ(OTT)ビデオ市場
    Summary A new report by Pyramid Research, 'OTT Video Market Attractiveness Index: Worldwide Country Rankings, Market Drivers and Positioning Strategies,' examines the growth potential of OTT video services worldwide, providing insight into the opportunity to derive value from them. In order to assess the strength of the OTT video opportunity in different countries, Pyramid Research has especially …
  • ハイブリッドファブリックの世界市場予測(~2024年)
    ”The hybrid fabric market is projected to register a CAGR of 16.0%, in terms of value, between 2019 and 2024.’’ The hybrid fabric market size is estimated at USD 197 million in 2019 and is projected to reach USD 415 million by 2024, at a CAGR of 16.0% between 2019 and 2024. Hybrid fabric offers various benefits such as non-corrosiveness, high stiffness, non-conductivity, flexibility, low maintenan …
  • カーワックスの世界市場2019-2023
    Technavio Announces the Publication of its Research Report – Global Car Wax Market 2019-2023 Technavio recognizes the following companies as the key players in the global car wax market: 3M, Henkel AG & Co. KGaA, Malco Products, Inc, Mothers, SONAX GmbH, Turtle Wax. Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the increase in …
  • パイプライン・ピギング装置の世界市場2017-2021
    About Pipeline Pigging Systems The augmented oil and gas demands need significant support from the associated infrastructure for the market to develop. In this respect, the global pipeline infrastructure has expanded by a factor of almost 100 in the past half a century. The pipelines associated in the oil and gas business are utilized to transport a multitude of commodities over various distances. …
  • 軍事用レーザー照射機の世界市場2017-2021
    About Military Laser DesignatorA laser designator can be used to call in for accurate and precise ground or aerial strikes from a distant range (approximately within 10 miles). These systems are either man-portable or are mounted on vehicles, aircraft, or ships. Technavio’s analysts forecast the global military laser designator market to grow at a CAGR of 5.07% during the period 2017-2021. [Covere …
  • 世界のエネルギー管理情報システム市場動向(2014~2018)
    TechNavio's analysts forecast the Global Energy Management Information System market to grow at a CAGR of 5.07 percent over the period 2013-2018. One of the key factors contributing to this market growth is the emergence of the Process Automation industry. The Global Energy Management Information System market has also been witnessing the increase in the usage of computer-based systems in the Ener …
  • 飲料用安定剤の世界市場:製品種類別(アラビアゴム、カルボキシメチルセルロース、キサンタンガム、カラギーナン、ペクチンなど)、飲料種類別(果物飲料、乳製品飲料、清涼飲料、アルコール飲料、その他)
    Beverage stabilizers can be defined as food additives that prevents degradation in beverages and help in maintaining consistency by keeping additional ingredients suspended in the solution for a longer period of time. Modified starch, pectin, carrageenan, casein inulin, and hydrocolloids are among the most commonly used beverage stabilizers. There is a substantial increase in the worldwide demand …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。